These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 7606878)
1. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 in chronic renal failure and dialysis patients. Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257 [TBL] [Abstract][Full Text] [Related]
3. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [TBL] [Abstract][Full Text] [Related]
4. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis. Fieren MW; van den Bemd GJ; Bonta IL Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787 [TBL] [Abstract][Full Text] [Related]
5. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients. Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784 [TBL] [Abstract][Full Text] [Related]
6. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
8. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis. Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response. Wang HH; Lin CY Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis. Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Brauner A; Hylander B; Wretlind B Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710 [TBL] [Abstract][Full Text] [Related]
12. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Gu Y; Ding F; Qin H; Zhao H; Lin S Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226 [TBL] [Abstract][Full Text] [Related]
13. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer. Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196 [TBL] [Abstract][Full Text] [Related]
14. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis? Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267 [TBL] [Abstract][Full Text] [Related]
15. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis. Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158 [TBL] [Abstract][Full Text] [Related]
16. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [TBL] [Abstract][Full Text] [Related]
17. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease. Holmlund A; Hänström L; Lerner UH J Clin Periodontol; 2004 Jun; 31(6):475-82. PubMed ID: 15142219 [TBL] [Abstract][Full Text] [Related]
18. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. O'Nualláin EM; Puri P; Mealy K; Reen DJ Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873 [TBL] [Abstract][Full Text] [Related]
19. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]